$12.5 Million NIH Grant Awarded to Continue Hidden Hearing Loss Research
A team of Mass Eye and Ear researchers in the Eaton-Peabody Laboratories have been awarded a five-year, $12.5 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders (NIDCD) of the National Institute of Health (NIH) to continue their research on cochlear synaptopathy, or hidden hearing loss, a type of hearing damage first discovered at Mass Eye and Ear in 2009.
Funding from the grant extends support of four projects that aim to clarify the prevalence, nature, and functional consequences of hidden hearing loss in humans. The work promises to inform cellular-based diagnosis and development of future therapies. Each of the related projects is led by a separate principal investigator.
Sharon Kujawa, Ph.D., presented on the topic of hidden hearing loss in a webinar that was recorded and captioned, available at hhf.org/webinar.
Sharon Kujawa, Ph.D., the Sheldon and Dorothea Buckler Chair of Otolaryngology at Mass Eye and Ear and professor of otolaryngology–head and neck surgery at Harvard Medical School; Charles Liberman, Ph.D., professor of otolaryngology–head and neck surgery at Harvard Medical School; Stéphane Maison, Au.D., Ph.D., CCC-A, associate professor of otolaryngology–head and neck surgery at Harvard Medical School; and Daniel Polley, Ph.D., professor of otolaryngology–head and neck surgery at Harvard Medical School and interim director of the Eaton-Peabody Laboratories, are the collaborating Mass Eye and Ear principal investigators on the projects. Kujawa is the program director overseeing the entirety of the grant.
Under the initial grant, the research team focused on detecting and characterizing hidden hearing loss in humans and animals with normal hearing thresholds. With the new grant, their focus will expand to detecting this hearing damage in the presence of hearing loss as traditionally defined by a clinical audiogram, as well as to better understanding the consequences of this damage in hearing function.
“The discovery of hidden hearing loss has forever changed the way the way clinicians think about hearing loss, from its diagnosis and to its treatment,” says Mark A. Varvares, M.D., FACS, the chief of the departments of otolaryngology–head and neck surgery at Mass Eye and Ear and Massachusetts General Hospital. “The continuation of this P50 grant is another example of our commitment to pioneering life-changing diagnostics and cures at Mass Eye and Ear.”
Hidden Hearing Loss
The audiogram has long been used by clinicians as the gold-standard for hearing tests. The test reflects the health of sensory cells in the inner ear, called hair cells, which convert sound into electrical signals. While the health of these cells can determine a person’s hearing threshold, or how loud a sound needs to be in order for a person to hear it, the thresholds do not reveal how clearly sounds are heard. A healthy auditory nerve, able to faithfully transmit sound information to the brain, plays a crucial role.
In 2009, Kujawa and Liberman discovered that exposure to noise destroys the synapses connecting hair cells to the auditory nerve well-before the noise damaged hair cells, which meant hearing damage could exist before it was revealed by the audiogram.
“We used to think that if thresholds recovered to normal after exposure to noise, then there was no lasting ear damage, which we’ve come to find out isn’t the case,” Kujawa says. “Rather, it’s as if the loss was ‘hidden’ in the normal audiogram.”
This prompted the researchers to evaluate widespread neural degeneration in patients who had hearing difficulties, but also had normal audiogram measurements.
New Grant to Build on Earlier Projects
Since Kujawa and Liberman’s 2009 discovery, investigators have made it a priority to understand what hidden hearing loss is, what causes it and how to identify it. In 2017, the NIH awarded Kujawa, Liberman, Maison and Polley a P50 grant to research this new type of hearing damage from multiple angles. Through four separate projects, including one studying donated human temporal bones, one focusing on animal models of human hearing loss and two working with human subjects, the team of researchers has found widespread evidence of neural degeneration hidden behind normal audiogram measurements.
Their research also unveiled several new clues about this new type of hearing damage. Growing evidence has suggested that perceptual disorders, some as mild as difficulty hearing in a noisy environment, or as potentially debilitating as tinnitus and hyperacusis, could share a common tie to neural degeneration. Additionally, studies found that sound deprivation—not just aging, loud noises, or ototoxic drugs—can lead to neural degeneration.
According to Kujawa, evaluating human and animal subjects with overt hearing loss under the new P50 grant will bring investigators a step closer to devising sensitive diagnostic tools, thereby making it possible to apply future therapeutics to prevent, limit or reverse cochlear neural degeneration.
“Right now, we have therapeutics on the horizon that have shown the potential to repair or reconnect these nerve fibers in the inner ear,” she says. “If we can improve our tests so they show us who has neural degeneration and who doesn’t, then we can test the efficacy of these therapeutics, which would be a big advance for hearing loss research and clinical treatment.”
This is adapted from a press release by Mass Eye and Ear. Research reported above was supported by the National Institute on Deafness And Other Communication Disorders of the National Institutes of Health under Award Number P50DC015857.
A 1999 Emerging Research Grants alumna, Kujawa is a member of HHF’s Board of Directors and a member of HHF’s Council of Scientific Trustees, which oversees the Emerging Research Grants program. She presented research on hidden hearing loss for our Hearing Health Hour webinar.